FGF21 and obesity due to melanocortin 4 receptor deficiency: Besides its metabolic attributes, FGF21 also seems to have an anti-inflammatory effect, which has been observed in patients with type 2 diabetes mellitus (T2DM) and diabetic peripheral neuropathy [8,9,10], and it seems to ameliorate obesity-related hypothalamic inflammation [4,11].